Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

norbormide

Known as: 5-(alpha-hydroxy-alpha-2-pyridylbenzyl)-7- (alpha-2-pyridylbenzylidene)-5-norbornene-2,3- dicarboximide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Norbormide [5-(alpha-hydroxy-alpha-2-pyridylbenzyl)-7-(alpha-2-pyridylbenzylidene)-5-norbornene-2,3-dicarboximide] (NRB, 1), an… Expand
2005
2005
In the present study, we show that norbormide stimulates the opening of the permeability transition pore (PTP) in mitochondria… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2003
2003
We have investigated the effects of the rat-specific vasoconstrictor agent norbormide on the mechanical and electrophysiological… Expand
2002
2002
Norbormide, a selective rat toxicant, was microencapsulated to both mask the flavour and delay the release until after a lethal… Expand
2002
2002
Aim of the present study was to investigate the effects of norbormide, a selective vasoconstrictor agent of the rat peripheral… Expand
2001
2001
Norbormide (NRB) is a selective vasoconstrictor agent of the rat small vessels. The mechanisms underlying the selective… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
1997
1997
Cardiac effects of norbormide and verapamil were compared in single ventricular myocytes, right atria, and Langendorff perfused… Expand
1996
1996
1 The effects of norbormide on the contractility of endothelium‐deprived rat, guinea‐pig, mouse, and human artery rings, and of… Expand
1968
1968
Norbormide has already been compared with zinc phosphide under laboratory conditions against normal and warfarin-resistant… Expand
1965
1965
  • A. Roszkowski
  • The Journal of pharmacology and experimental…
  • 1965
  • Corpus ID: 40809588
The pharmacological properties of 5-(α hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)-5-norbornene-2,3-dicarboximide… Expand